Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (591-600 of 608) with videos related to

Pageof 61
Sort By:
European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
Heart (British Cardiac Society)|June 25, 2025
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trialPablo Salinas, Rafael Romaguera, Josep Gómez-Lara, et al.
Alzheimer'S Research & Therapy|April 17, 2026
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS studyNúria Tort-Colet, Laura Stankeviciute, Ana Fernández-Arcos, et al.
BMC Cardiovascular Disorders|December 15, 2015
Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trialMencia Benitez-Camps, Ernest Vinyoles-Bargalló, Oriol Rebagliato-Nadal, et al.
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
Diabetes Technology & Therapeutics|July 29, 2025
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential StudyPedro Pujante Alarcón, Elías Delgado Álvarez, Carmen Lambert Goitia, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 61

Showing results (591-600 of 608) with videos related to

Sort By:
Pageof 61
European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
Heart (British Cardiac Society)|June 25, 2025
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trialPablo Salinas, Rafael Romaguera, Josep Gómez-Lara, et al.
Alzheimer'S Research & Therapy|April 17, 2026
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS studyNúria Tort-Colet, Laura Stankeviciute, Ana Fernández-Arcos, et al.
BMC Cardiovascular Disorders|December 15, 2015
Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trialMencia Benitez-Camps, Ernest Vinyoles-Bargalló, Oriol Rebagliato-Nadal, et al.
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
Diabetes Technology & Therapeutics|July 29, 2025
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential StudyPedro Pujante Alarcón, Elías Delgado Álvarez, Carmen Lambert Goitia, et al.
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 61